Benzinga | Nov 11, 2021 06:53AM EST

TherapeuticsMD Q3 EPS $(0.11) Misses $(0.10) Estimate, Sales $24.50M Miss $25.87M Estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $24.50 million which missed the analyst consensus estimate of $25.87 million by 5.30 percent. This is a 26.67 percent increase over sales of $19.34 million the same period last year.